Cancer Biomarkers

A cancer biomarker refers to a substance or technique this is indicative of the presence of cancer inside the frame. A biomarker may be a molecule secreted via a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer prognosis, diagnosis, and epidemiology. Whilst a few most cancers biomarkers can be used to be expecting how aggressively your cancer will develop, and are consequently beneficial for assessing your analysis, the maximum promising use of biomarkers these days is to pick out which cures a patient’s cancer may additionally or might not respond to.

  • Diagnostic Biomarkers
  • Predictive & Prognostic Biomarkers
  • Tumour Suppressors Biomarkers
  • Molecular Cancer Biomarkers

Related Conference of Cancer Biomarkers

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in